
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1060 | 1074 | 1168 | 1270 | 1461 | 1954 |
Fund Return | 5.96% | 7.39% | 16.82% | 8.29% | 7.88% | 6.93% |
Place in category | 1148 | 377 | 161 | 210 | 589 | 156 |
% in Category | 57 | 16 | 7 | 11 | 39 | 14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Goldman Sachs Global CORE Equity Pe | 5.24B | 3.35 | 11.98 | 10.12 | ||
GS Global CORE Equity Portfolio E C | 5.24B | 3.15 | 11.24 | 10.13 | ||
GS Global CORE Equity Portfolio I E | 5.24B | 3.25 | 12.68 | 11.59 | ||
GS India Equity Portfolio E Acc | 4.35B | -15.47 | 7.38 | 7.54 | ||
GS S GS Europe CORE Equity Portfolb | 3.14B | 6.00 | 8.83 | 7.46 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund A Acc EUR | 166.21M | 7.62 | 9.17 | 4.81 | ||
European Growth Fund E Acc EUR | 22.23M | 7.50 | 8.35 | 4.03 | ||
European Growth Fund Y Acc EUR | 237.38M | 7.77 | 10.09 | 5.69 | ||
European Growth Fund Y DIST EUR | 66.18M | 5.88 | 7.91 | 6.31 | ||
European Growth Fund A DIST Eue | 6.66B | 5.81 | 6.98 | 5.44 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SAP | DE0007164600 | 4.07 | 242.550 | +1.63% | |
Novo Nordisk B | DK0062498333 | 3.26 | 507.6 | -4.32% | |
Novartis | CH0012005267 | 2.97 | 96.31 | +0.64% | |
Nestle | CH0038863350 | 2.72 | 89.04 | +0.50% | |
Siemens AG | DE0007236101 | 2.28 | 226.85 | +1.64% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review